Profil

Van Kemseke Catherine

Département des sciences cliniques

See author's contact details
Main Referenced Co-authors
Louis, Edouard  (46)
Reenaers, Catherine  (35)
Vieujean, Sophie  (17)
Belaiche, Jacques  (16)
Latour, Pascale  (15)
Main Referenced Keywords
Crohn's disease (12); Humans (11); inflammatory bowel disease (4); Adult (3); confocal endomicroscopy (3);
Main Referenced Unit & Research Centers
BIRD (1)
Laboratoire de gastro-entérologie translationnelle (1)
Main Referenced Disciplines
Gastroenterology & hepatology (51)
General & internal medicine (2)
Immunology & infectious disease (2)
Endocrinology, metabolism & nutrition (1)
Radiology, nuclear medicine & imaging (1)

Publications (total 56)

The most downloaded
2369 downloads
Bonnet, C., LEJEUNE, M., VAN KEMSEKE, C., Bron, D., & Beguin, Y. (2015). Prise en charge actuelle du lymphome de la zone marginale. Revue Médicale Suisse, 11, 1549-1556. https://hdl.handle.net/2268/192584

The most cited

101 citations (Scopus®)

Louis, E., Belaiche, J., Van Kemseke, C., Franchimont, D., de Groote, D., Geenen, V., & Mary, J. Y. (October 1997). A High Serum Concentration of Interleukin-6 Is Predictive of Relapse in Quiescent Crohn's Disease. European Journal of Gastroenterology and Hepatology, 9 (10), 939-44. doi:10.1097/00042737-199710000-00004 https://hdl.handle.net/2268/23730

Pierre, N., Huynh-Thu, V. A., Baiwir, D., VIEUJEAN, S., Bequet, E., Reenaers, C., Van Kemseke, C., Salée, C., Massot, C., Fleron, M., Mazzucchelli, G., Trzpiot, L., Eppe, G., De Pauw, E., Louis, E., & Meuwis, M.-A. (2024). Serum proteome signatures associated with ileal and colonic ulcers in Crohn's disease. Journal of Proteomics, 105199. doi:10.1016/j.jprot.2024.105199
Peer Reviewed verified by ORBi

Pierre, N., Huynh-Thu, V. A., Baiwir, D., VIEUJEAN, S., Bequet, E., Reenaers, C., Van Kemseke, C., Salée, C., Massot, C., Fleron, M., Mazzucchelli, G., Trzpiot, L., Eppe, G., De Pauw, E., Louis, E., & Meuwis, M.-A. (02 February 2024). Distinct blood protein profiles associated with ileal and colonic ulcers in Crohn’s disease [Poster presentation]. Belgian Week of Gastroenterology 2024, Antwerp, Belgium.
Peer reviewed

Pierre, N., Huynh-Thu, V. A., Baiwir, D., VIEUJEAN, S., Bequet, E., Reenaers, C., Van Kemseke, C., Salée, C., Massot, C., Fleron, M., Mazzucchelli, G., Trzpiot, L., Eppe, G., De Pauw, E., Louis, E., & Meuwis, M.-A. (2024). Distinct blood protein profiles associated with ileal and colonic ulcers in Crohn’s disease [Paper presentation]. Belgian Week of Gastroenterology 2024.
Peer reviewed

Pierre, N., Huynh-Thu, V. A., Baiwir, D., VIEUJEAN, S., Bequet, E., Reenaers, C., Van Kemseke, C., Salée, C., Massot, C., Fleron, M., Mazzucchelli, G., Trzpiot, L., Eppe, G., De Pauw, E., Louis, E., & Meuwis, M.-A. (2024). Distinct blood protein profiles associated with ileal and colonic ulcers in Crohn’s disease [Poster presentation]. European Crohn's and Colitis Organisation 2024, Stockholm, Sweden.
Peer reviewed

MONIN, L., Reenaers, C., Grandfils, S., Latour, P., Van Kemseke, C., KROPP, S., Louis, E., & VIEUJEAN, S. (2024). Outcomes in patients stopping biologic during the first trimester of pregnancy : a retrospective monocentric study [Poster presentation]. Belgian Week of Gastroenterology 2024.
Peer reviewed

MONIN, L., Reenaers, C., Grandfils, S., Latour, P., Van Kemseke, C., KROPP, S., Louis, E., & VIEUJEAN, S. (2024). Outcomes in patients stopping biologic during the first trimester of pregnancy : a retrospective monocentric study [Poster presentation]. European Crohn's and Colitis Organisation 2024.
Peer reviewed

Loly, J.-P., Vieujean, S., Reenaers, C., Van Kemseke, C., Seidel, L., Louis, E., & Somja, J. (2023). In-Depth Assessment of Endoscopic Remission in Inflammatory Bowel Disease Treated by Anti-TNF or Vedolizumab. Inflammatory Bowel Diseases. doi:10.1093/ibd/izad066
Peer Reviewed verified by ORBi

Vieujean, S., GILLARD, R., Calvaer, F., Chayeb, M., Seidel, L., Reenaers, C., KROPP, S., Van Kemseke, C., Latour, P., Louis, E., & Meunier, P. (March 2023). Assessment of therapeutic response in Crohn’s disease by dynamic contrast enhanced MRI [Poster presentation]. 35th Belgian Week of Gastroenterology 2023.
Peer reviewed

Peyrin-Biroulet, L., Rahier, J.-F., Kirchgesner, J., Abitbol, V., Shaji, S., Armuzzi, A., Karmiris, K., Gisbert, J. P., Bossuyt, P., Helwig, U., Burisch, J., Yanai, H., Doherty, G. A., Magro, F., Molnar, T., Löwenberg, M., Halfvarson, J., Zagorowicz, E., Rousseau, H., ... Coutard, L. (Other coll.). (March 2023). I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease. Clinical Gastroenterology and Hepatology, 21 (3), 771-788.e10. doi:10.1016/j.cgh.2022.09.018
Peer Reviewed verified by ORBi

Vieujean, S., GILLARD, R., Calvaer, F., Chayeb, M., Seidel, L., Reenaers, C., KROPP, S., Van Kemseke, C., Latour, P., Louis, E., & Meunier, P. (March 2023). Assessment of therapeutic response in Crohn’s disease by dynamic contrast enhanced MRI [Poster presentation]. 35th Belgian Week of Gastroenterology 2023.
Peer reviewed

Gofflot, A., MONIN, L., Seidel, L., Reenaers, C., KROPP, S., Van Kemseke, C., Latour, P., Forthomme, B., Croisier, J.-L., Louis, E., & Vieujean, S. (March 2023). Impact of different types of physical activity in inflammatory bowel disease [Paper presentation]. 35th Belgian Week of Gastroenterology 2023.
Peer reviewed

Gofflot, A., MONIN, L., Seidel, L., Reenaers, C., KROPP, S., Van Kemseke, C., Latour, P., Forthomme, B., Croisier, J.-L., Louis, E., & Vieujean, S. (March 2023). Impact of different types of physical activity in inflammatory bowel disease [Poster presentation]. 18th Congress of European Crohn's and Colitis Organisation 2023.
Peer reviewed

Loly, J.-P., Vieujean, S., Reenaers, C., Van Kemseke, C., Seidel, L., Somja, J., & Louis, E. (March 2022). Remission state in inflammatory bowel disease patients on anti-TNF or vedolizumab: a confocal endomicroscopy study [Paper presentation]. 34th Belgian Week of Gastroenterology 2022.
Peer reviewed

AMICONE, C., Marques, C. C., Reenaers, C., Van Kemseke, C., Seidel, L., & Louis, E. (2022). Early Post-Operative Endoscopy Is Associated with Lower Surgical Recurrence of Crohn's Disease: A Retrospective Study of Three Successive Cohorts. Gastroenterology Research and Practice, 2022, 6341069. doi:10.1155/2022/6341069
Peer Reviewed verified by ORBi

LOLY, J.-P., VIEUJEAN, S., REENAERS, C., VAN KEMSEKE, C., SEIDEL, L., SOMJA, J., & LOUIS, E. (01 January 2022). P234 Remission state in Inflammatory Bowel Disease patients on anti TNF or vedolizumab: a confocal endomicroscopy study. Journal of Crohn's and Colitis, 16 (Supplement_1), 283-i283. doi:10.1093/ecco-jcc/jjab232.361
Peer Reviewed verified by ORBi

VIEUJEAN, S., LATOUR, P., COIMBRA MARQUES, C., DELVENNE, P., LOUIS, E., & VAN KEMSEKE, C. (2021). Unusual intra-rectal “laterally spreading tumour” in immunosuppressed patient with ulcerative colitis. Acta Gastro-Enterologica Belgica. doi:10.51821/84.3.018
Peer Reviewed verified by ORBi

De Schepper, H., Coremans, G., Denis, M. A., Dewint, P., Duinslaeger, M., Gijsen, I., Haers, P., Komen, N., Remue, C., Roelandt, P., Somers, M., Surmont, M., Van de Putte, D., Van den Broeck, S., VAN KEMSEKE, C., & De Looze, D. (2021). Belgian consensus guideline on the management of hemorrhoidal disease. Acta Gastro-Enterologica Belgica, 84 (1), 101-120. doi:10.51821/84.1.497
Peer Reviewed verified by ORBi

Monin, L., Dubois, S., REENAERS, C., VAN KEMSEKE, C., LATOUR, P., VAN DAELE, D., VIEUJEAN, S., SEIDEL, L., & Louis, E. (2021). Ustekinumab in bio-naïve and bio-failure Crohn's disease patients: Results from a « real-life » monocentric cohort. Digestive and Liver Disease. doi:10.1016/j.dld.2020.10.040
Peer reviewed

Kouam, C., WARLING, O., VAN KEMSEKE, C., LOLY, J.-P., Louis, E., & Delwaide, J. (2020). Risques néoplasiques majorés dans la rectocolite ulcéro-hémorragique associée à la cholangite sclérosante primitive. Revue Médicale de Liège, 75 (11), 724-730.
Peer reviewed

Preda, C., Manuc, T., Chifulescu, A. E., Istratescu, D., Louis, E., Baicus, C., Sandra, I., Diculescu, M., Reenaers, C., VAN KEMSEKE, C., Nitescu, M., Tieranu, C., Popescu, M. C., Tugui, L., Andrei, A., Ciora, C.-A., Gheorghe, L.-S., & Manuc, M. (2020). Diet as an environmental trigger in inflammatory bowel disease: A retrospective comparative study in two European cohorts. Revista Espanola de Enfermedades Digestivas, 112 (6), 440-447. doi:10.17235/reed.2020.6552/2019

VIEUJEAN, S., BURY, T., GASPARD, L., GIOT, J.-B., MAWEJA, S., LOUIS, E., & VAN KEMSEKE, C. (February 2019). Ganglionic tuberculosis in a Crohn’s disease patient treated by infliximab despite anti-tuberculosis chemoprophylaxis [Paper presentation]. Belgian Week of Gastroenterology 31st Edition - BWGE 2019.
Peer reviewed

Preda, C. M., Manuc, T., Istratescu, D., Louis, E., Baicus, C., Sandra, I., Diculescu, M., REENAERS, C., VAN KEMSEKE, C., Nitescu, M., Tieranu, C., Sandu, C. G., Oprea-Calin, G., Tugui, L., Viziru, S., Ciora, C.-A., Gheorghe, L.-S., & Manuc, M. (2019). Environmental Factors in Romanian and Belgian Patients with Inflammatory Bowel Disease - a Retrospective Comparative Study. Mædica, 14 (3), 233-239. doi:10.26574/maedica.2019.14.3.233

Liefferinckx, C., Verstockt, B., Gils, A., Noman, M., VAN KEMSEKE, C., Macken, E., De Vos, M., Van Moerkercke, W., Rahier, J.-F., Bossuyt, P., Dutre, J., Humblet, E., Staessen, D., Peeters, H., Van Hootegem, P., Louis, E., Franchimont, D., Baert, F., & Vermeire, S. (2019). Long-term Clinical Effectiveness of Ustekinumab in Patients with Crohn's Disease Who Failed Biologic Therapies: A National Cohort Study. Journal of Crohn's & colitis, 13 (11), 1401-1409. doi:10.1093/ecco-jcc/jjz080

Pierre, N., Salee, C., MASSOT, C., BLETARD, N., Mazzucchelli, G., Smargiasso, N., Morsa, D., Baiwir, D., De Pauw, E., REENAERS, C., VAN KEMSEKE, C., LOLY, J.-P., Delvenne, P., Meuwis, M.-A., & Louis, E. (2019). Proteomics highlights common and distinct pathophysiological processes associated with ileal and colonic ulcers in Crohn's disease. Journal of Crohn's & colitis. doi:10.1093/ecco-jcc/jjz130
Peer reviewed

Pierre, N., REENAERS, C., VAN KEMSEKE, C., LOLY, J.-P., Mazzucchelli, G., Smargiasso, N., Baiwir, D., De Pauw, E., MEUWIS, M.-A., & LOUIS, E. (February 2018). Proteomic analysis highlights divergences and convergences between ileal and colonic pathological processes involved in Crohn’s ulcers [Poster presentation]. 30th edition of the Belgian Week of Gastroenterology, Anvers, Belgium.

Pierre, N., REENAERS, C., VAN KEMSEKE, C., LOLY, J.-P., Mazzucchelli, G., Smargiasso, N., Baiwir, D., Morsa, D., De Pauw, E., MEUWIS, M.-A., & Louis, E. (2018). Proteomic analysis highlights divergences and convergences between ileal and colonic pathological processes involved in Crohn’s ulcers. Journal of Crohn's and Colitis. doi:10.1093/ecco-jcc/jjx180.184
Peer Reviewed verified by ORBi

VIEUJEAN, S., LATOUR, P., COIMBRA MARQUES, C., LOUIS, E., & VAN KEMSEKE, C. (February 2018). Curious intra-rectal “laterally spreading tumor” in immunosuppressed patient with ulcerative colitis [Paper presentation]. Belgian Week of Gastroenterology 30th Edition - BWGE 2018.
Peer reviewed

Louis, E., VAN KEMSEKE, C., & REENAERS, C. (2017). Objective assessment of clinical disease activity. In D. C. Baumgart (Ed.), Crohn's Disease and Ulcerative Colitis: From Epidemiology and Immunobiology to a Rational Diagnostic and Therapeutic Approach (pp. 259-266). Springer, Cham - D.C. Baumgart (ed.). doi:10.1007/978-3-319-33703-6_23

Bello, C., Roseth, A., Guardiola, J., REENAERS, C., Ruiz-Cerulla, A., VAN KEMSEKE, C., Arajol, C., Reinhard, C., SEIDEL, L., & Louis, E. (2017). Usability of a home-based test for the measurement of fecal calprotectin in asymptomatic IBD patients. Digestive and Liver Disease, 49 (9), 991-996. doi:10.1016/j.dld.2017.05.009
Peer Reviewed verified by ORBi

DESIR, C., COIMBRA MARQUES, C., Decker, M., REENAERS, C., VAN KEMSEKE, C., LATOUR, P., Louis, E., & Meunier, P. (2017). Comment j'explore ... la maladie de Crohn par imagerie. Revue Médicale de Liège, 72 (1), 51-56.
Peer reviewed

LOLY, J.-P., SOMJA, J., REENAERS, C., VAN KEMSEKE, C., GAST, P., & Louis, E. (2017). Endomicroscopie confocale dans la prise en charge des maladies inflammatoires chroniques de l'intestin. Revue Médicale Suisse, 13 (571), 1431-1434.
Peer Reviewed verified by ORBi

REENAERS, C., Pirard, C., VAN KEMSEKE, C., LATOUR, P., Belaiche, J., & Louis, E. (2016). Long-term evolution and predictive factors of mild inflammatory bowel disease. Scandinavian Journal of Gastroenterology, 51 (6), 712-9. doi:10.3109/00365521.2015.1128965
Peer Reviewed verified by ORBi

Louis, E., REENAERS, C., VAN KEMSEKE, C., LATOUR, P., BELAICHE, J., MEUNIER, P., & COIMBRA MARQUES, C. (2015). De l'"Evidence-based Medecine" à la médecine personnalisée dans la maladie de Crohn. Revue Médicale de Liège, 70 (5-6), 316-320.

Van Kemseke, C., Louis, E., & REENAERS, C. (2015). LE MEDICAMENT DU MOIS. Vedolizumab (Entyvio(R)), nouveau traitement des maladies inflammatoires intestinales. Revue Médicale de Liège, 70 (11), 575-82.
Peer reviewed

Bonnet, C., LEJEUNE, M., VAN KEMSEKE, C., Bron, D., & Beguin, Y. (2015). Prise en charge actuelle du lymphome de la zone marginale. Revue Médicale Suisse, 11, 1549-1556.
Peer Reviewed verified by ORBi

MEUNIER, P., COUSIN, F., VAN KEMSEKE, C., REENAERS, C., LATOUR, P., BELAICHE, J., SEIDEL, L., & LOUIS, E. (2015). Persisting signs of disease activity at magnetic resonance enterocolonography predict clinical relapse and disease progression in quiescent Crohn's disease. Acta Gastro-Enterologica Belgica, 73 (3), 274-81.
Peer Reviewed verified by ORBi

Poncin, M., REENAERS, C., VAN KEMSEKE, C., Belaiche, J., Seidel, L., MEUNIER, P., & Louis, E. (2014). Depth of remission in Crohn's disease patients seen in a referral centre : associated factors and impact on disease outcome. Acta Gastro-Enterologica Belgica, 77 (1), 41-6.
Peer Reviewed verified by ORBi

VAN KEMSEKE, C. (2014). Constipation et troubles de la continence fécale chez le sujet âgé. Revue Médicale de Liège, 69 (5-6), 337-42.
Peer reviewed

Benitez, J.-M., Meuwis, M.-A., REENAERS, C., VAN KEMSEKE, C., Meunier, P., & Louis, E. (2013). Role of endoscopy, cross-sectional imaging and biomarkers in Crohn's disease monitoring. Gut, 62 (12), 1806-16. doi:10.1136/gutjnl-2012-303957
Peer Reviewed verified by ORBi

Louis, E., REENAERS, C., Meuwis, M.-A., VAN KEMSEKE, C., LATOUR, P., CHAPELIER, N., WERTZ, S., COIMBRA MARQUES, C., MEUNIER, P., & Belaiche, J. (March 2012). Quinze ans d'anti-TNF dans la maladie de Crohn: comment tirer le meilleur de cette revolution therapeutique? Revue Médicale de Liège, 67 Spec No, 8-13.
Peer reviewed

Louis, E., GAST, P., VAN KEMSEKE, C., & REENAERS, C. (2012). Commentary: endoscopic dilatation for stricturing Crohn's disease. Alimentary Pharmacology and Therapeutics, 36 (5), 494-6. doi:10.1111/j.1365-2036.2012.05209.x
Peer Reviewed verified by ORBi

Louis, E., VAN KEMSEKE, C., LATOUR, P., Belaiche, J., & REENAERS, C. (2012). Genetique et environnement dans les maladies inflammatoires chroniques de l'intestin. Revue Médicale de Liège, 67 (5-6), 298-304.
Peer reviewed

Louis, E., VAN KEMSEKE, C., & Reenaers, C. (2011). Necessity of phenotypic classification of inflammatory bowel disease. Best Practice and Research. Clinical Gastroenterology, 25 Suppl 1, 2-7. doi:10.1016/S1521-6918(11)70003-8
Peer Reviewed verified by ORBi

Van Kemseke, C. (2009). Sexually transmitted diseases and anorectum. Acta Gastro-Enterologica Belgica, 72 (4), 413-9.
Peer Reviewed verified by ORBi

De Roover, A., Coimbra Marques, C., Detry, O., Van Kemseke, C., Squifflet, J.-P., Honore, P., & Meurisse, M. (27 September 2007). Pancreas graft drainage in recipient duodenum: Preliminary experience. Transplantation, 84 (6), 795-797. doi:10.1097/01.tp.0000281401.88231.da
Peer Reviewed verified by ORBi

Van Kemseke, C., & Belaiche, J. (2004). Medical treatment of chronic anal fissure. Where do we stand on reversible chemical sphincterotomy? Acta Gastro-Enterologica Belgica, 67 (3, Jul-Sep), 265-271.
Peer Reviewed verified by ORBi

Van Kemseke, C., Belaiche, J., Steeman, C., & Louis, E. (2003). Negative association between smoking and anti-saccharomyces cerevisiae antibodies in Crohn's disease. Acta Gastro-Enterologica Belgica, 66 (1, Jan-Mar), 1-6.
Peer Reviewed verified by ORBi

Van Kemseke, C., Belaiche, J., & Louis, E. (August 2000). Frequently Relapsing Crohn's Disease Is Characterized by Persistent Elevation in Interleukin-6 and Soluble Interleukin-2 Receptor Serum Levels During Remission. International Journal of Colorectal Disease, 15 (4), 206-10. doi:10.1007/s003840000226
Peer Reviewed verified by ORBi

Van Kemseke, C., & Belaiche, J. (May 2000). Recommandations dans la prise en charge de l'Helicobacter pylori: point de vue recent de la Societe nationale francaise de Gastroenterologie. Revue Médicale de Liège, 55 (5), 345-9.

Van Kemseke, C., & Belaiche, J. (July 1999). Controverses dans le traitement de l'Helicobacter pylori. Revue Médicale de Liège, 54 (7), 570-5.

Belaiche, J., Van Kemseke, C., & Louis, E. (May 1999). Use of the Enteroscope for Colo-Ileoscopy: Low Yield in Unexplained Lower Gastrointestinal Bleeding. Endoscopy, 31 (4), 298-301. doi:10.1055/s-1999-17
Peer Reviewed verified by ORBi

Louis, E., Belaiche, J., Van Kemseke, C., Franchimont, D., de Groote, D., Geenen, V., & Mary, J. Y. (October 1997). A High Serum Concentration of Interleukin-6 Is Predictive of Relapse in Quiescent Crohn's Disease. European Journal of Gastroenterology and Hepatology, 9 (10), 939-44. doi:10.1097/00042737-199710000-00004
Peer Reviewed verified by ORBi

Louis, E., Franchimont, D., Lamproye, A., Van Kemseke, C., Schaaf-Lafontaine, N., Mahieu, P., & Belaiche, J. (September 1995). Systemic Immune Response after Rectocolonic Administration of Ovalbumin in Mice. International Archives of Allergy and Immunology, 108 (1), 19-23. doi:10.1159/000237112
Peer Reviewed verified by ORBi

Louis, E., Belaiche, J., Van Kemseke, C., Schaaf-Lafontaine, N., Mahieu, P., & Mary, J. Y. (August 1995). Soluble Interleukin-2 Receptor in Crohn's Disease. Assessment of Disease Activity and Prediction of Relapse. Digestive Diseases and Sciences, 40 (8), 1750-6. doi:10.1007/BF02212697
Peer Reviewed verified by ORBi

Van Kemseke, C., & Krzesinski, J.-M. (1995). Curious association between methyldopa, hepatic cirrhosis and fibrosing alveolitis: a case report. European Journal of Internal Medicine, 6, 131.
Peer Reviewed verified by ORBi

Louis, E., Lamproye, A., FRANCHIMONT, D., Van Kemseke, C., Schaaf-Lafontaine, N., MAHIEU, P., & Belaiche, J. (1995). Induction of cellular, but not humoral, tolerance to ovalbumin by direct injection into digestive tract segments or mesenteric lymph nodes in mice. Regional Immunology, 6, 251-256.
Peer Reviewed verified by ORBi

Contact ORBi